Crimson Publishers Publish With Us Reprints e-Books Video articles


Global Journal of Endocrinological Metabolism

Genomic Medicine and Endocrine Autoimmunity as Key to Mitochondrial Disease

  • Open or Close Ian James Martins1,2,3*

    1Centre of Excellence in Alzheimer’s disease Research and Care, Edith Cowan University, Australia

    2School of Psychiatry and Clinical Neurosciences, the University of Western Australia, Australia

    3McCusker Alzheimer’s Research Foundation, Hollywood Medical Centre, Australia

    *Corresponding author: Ian Martins, School of Medical Sciences, Edith Cowan University, Western Australia 6009, Australia

Submission: May 23, 2018; Published: May 25, 2018

DOI: 10.31031/GJEM.2018.02.000534

ISSN 2637-8019
Volume2 Issue2


The diabetes epidemic and the induction of various chronic diseases are expected to affect approx. 592 people by the year 2035. Diabetes and its connections to endocrine autoimmunity [1-3] has become important to metabolic disease with relevance to the non alcoholic fatty liver disease (NAFLD) epidemic and neurodegenerative diseases [4]. The urgency to prevent the largest diabetes epidemic in history has now assessed multiple risk factors involved with induction of Type 3 diabetes connected to various chronic diseases [4].

Keywords:Global; Type 3 diabetes; Pandemic; Suprachiasmatic nucleus; Endocrine autoimmunity; Mitophagy; Sirtuin 1; Major histocompatibility complex; Immunogenic; Genomic medicine; Immune regulation; NAFLD; Species

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137